Clin2
NCT05641272Possibly a fitNot yet recruiting

Allergy shot for dust mite allergies

Allergic RhinitisAllergic AsthmaAllergic RhinoconjunctivitisAllergy to House Dust Mite

Part of Ear, nose & throat, Immune system & allergy, Infections, Lungs & breathing clinical trials.

This trial tests a new allergy shot that may reduce symptoms of dust mite allergies, like sneezing, runny nose, and itchy eyes. It might also help with mild asthma caused by dust mites.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
90 people
Ages
12 years to 60 years
Study type
Interventional

Who can take part

  • You are between 12 and 60 years old.
  • You have moderate to severe nasal or eye allergy symptoms from dust mites, with or without mild asthma.
  • You have a positive skin test or blood test for dust mite allergy.
  • You are not allergic to other common allergens like pollen, mold, or pet dander (or only mildly so).
  • You have not had allergy shots in the past 5 years.
  • You have a smartphone to track your symptoms.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06778213Recruiting· Phase 4
Allergy shots for dust mite allergies tested in a special room

This trial tests if allergy shots (allergen-specific immunotherapy) can reduce symptoms of moderate to severe dust mite allergy. You will be in a room that exposes you to dust mites to see how well the treatment works, compared to a placebo.

Wroclaw, DL
NCT07269509Not yet recruiting
Immunotherapy injection in tonsils for dust mite allergies

This study tests a new way to treat allergic rhinitis (hay fever) caused by dust mites. Instead of allergy shots under the skin or drops under the tongue, the treatment is given as an injection into the tonsils. It aims to reduce allergy symptoms like sneezing and a runny nose.

Wuhan, Hubei
NCT04435990Recruiting· Phase 3
Allergy shots for dust mites in teens and adults

This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.

Santiago de Compostela, A Coruña
NCT07452380Recruiting
Dust mite allergy shot therapy for kids with rhinitis or asthma

This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.

Hangzhou, Zhejiang
NCT07475715Not yet recruiting· Phase 2
Under-the-tongue immunotherapy for dust mite allergies

This study tests a daily under-the-tongue tablet or drops to reduce allergy symptoms caused by house dust mites. If you have allergic rhinitis and are bothered by dust mites, this treatment might help your nose feel better without needing shots.

Hefei, Anhui
NCT07348302Recruiting· Phase 3
Allergy tablet for dust mite rhinitis and asthma

This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.

Nueve de Julio, Buenos Aires

Hear when a new Allergic Rhinitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.